An implantable brain-computer interface (iBCI) allows a person to control an external computer or device using only their intent to move or speak.
An implantable brain-computer interface (iBCI) allows a person to control an external computer or device using only their intent to move or speak.
Chitnis is using a unique blend of clinical trials, genomic studies and personalized medicine to improve care for patients with multiple sclerosis at all ages.
An new approach approach that prioritizes maintaining lifelong brain health could prevent the onset of stroke, dementia and other diseases.
Visualizing brain inflammation is a groundbreaking technique that researchers can use to accelerate drug development for neurological diseases.
MGB researchers are identifying new connections between ultraprocessed foods and disease and developing new tools to help consumers make better food choices.
Shota is a postdoctoral research fellow in the Center for Genomic Medicine studying repeat expansion diseases such as Huntington’s disease.
Alex is researcher in the Department of Neurology at Massachusetts General Hospital studying new treatment strategies for neurofibromatosis.
Jay promised his grandfather he would find a cure for PSP, the rare neurological disease that took memories away from them.
Vanessa Merker,PhD, has spent her 14-year career at Mass General working to improve care for patients with schwannomatosis and NF2.
There are currently no therapeutics to treat children with traumatic brain injuries. How one Mass General researcher is working to change that.